gptkbp:instanceOf
|
gptkb:Company
|
gptkbp:annualVisitors
|
15%
|
gptkbp:awards
|
Best_Biotech_Company_2021
|
gptkbp:CEO
|
gptkb:John_Doe
|
gptkbp:clinicalTrials
|
Phase 3 Trials
|
gptkbp:collaborations
|
Global Health Initiative
|
gptkbp:employees
|
200
|
gptkbp:focus
|
Gene Therapy
|
gptkbp:foundedIn
|
2000
|
gptkbp:founder
|
Jane_Smith
|
gptkbp:headCoach
|
250
|
gptkbp:headquarters
|
gptkb:San_Diego,_California
|
https://www.w3.org/2000/01/rdf-schema#label
|
Innovative Biotech Solutions
|
gptkbp:industry
|
Biotechnology
|
gptkbp:investmentFocus
|
Venture_Capital_Firm_A
|
gptkbp:market
|
Global
|
gptkbp:mission
|
To innovate in biotechnology.
|
gptkbp:partnerships
|
gptkb:University_of_California
|
gptkbp:patentCitation
|
20
|
gptkbp:products
|
Biopharmaceuticals
|
gptkbp:researchAreas
|
Immunology
Oncology
Neurology
|
gptkbp:revenue
|
50 million USD
|
gptkbp:services
|
Research_and_Development
|
gptkbp:socialResponsibility
|
Community Health Programs
|
gptkbp:subsidiary
|
Innovative Therapeutics
Innovative_Diagnostics
|
gptkbp:vision
|
To improve global health.
|
gptkbp:website
|
www.innovativebiotech.com
|